Nephro Care India LimitedNEPHROCARECorporate

Healthcare Latest results: Jun 2026 4 quarters of data

₹85.40

MCap ₹141 Cr

Nephro Care India Limited — Stock analysis & AI research Nephro Care India Limited — Multibagger AI analysis Nephro Care India Limited — Seasonality — best & worst months Nephro Care India Limited — Live exchange announcements

🏭 Healthcare sector

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹29 Cr

Sales · Jun 2026

+68.4% YoY

₹4 Cr

Operating Profit · Jun 2026

+503.3% YoY

12.4%

OPM % · Jun 2026

+254.3% YoY

₹2 Cr

Net Profit · Jun 2026

+347.7% YoY

₹0.98

EPS · Jun 2026

+351.3% YoY

📝 Nephro Care India Limited — results explained

Quarter ended June 2026 (Q1 FY27)

Nephro Care India Limited reported revenue of ₹29 crore for the quarter ended June 2026 (Q1 FY27), up 68.4% from ₹17 crore in the same quarter last year, and up 8.2% sequentially over the March 2026 quarter.

The company swung to a net profit of ₹2 crore from a net loss of ₹1 crore a year earlier. Earnings per share (EPS) came in at ₹0.98.

Operating profit stood at ₹4 crore — an operating margin (OPM) of 12.4%, compared with 3.5% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Nephro Care India Limited posted revenue of ₹67 crore, with a net profit of ₹1 crore.

Valuation snapshot

At the current price of ₹85.40, NEPHROCARE has a market capitalisation of ₹141 crore.

Within the Healthcare industry, it is the 14th-largest of the 22 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 61.71%, foreign institutional investors (FIIs) 0.73%, domestic institutional investors (DIIs) 1.30%, public shareholders 36.27% of Nephro Care India Limited.

Promoter holding rose from 61.47% to 61.71% over the latest period.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹141 Cr

Current Price ?

₹85.4

P/E ?

N/A

Industry P/E ?

34.70

P/B ?

2.48

P/S ?

N/A

P/FCF ?

-25.19

Enterprise Value ?

₹141 Cr

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

N/A

OPM ?

N/A

Profit after tax (TTM) ?

N/A

EPS (TTM) ?

N/A

ROCE ?

N/A

ROE ?

N/A

ROA ?

N/A

Growth

Sales — latest qtr ?

₹29 Cr

PAT — latest qtr ?

₹2 Cr

YoY qtr sales growth ?

68.4%

YoY qtr profit growth ?

347.7%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹0 Cr

Debt to Equity ?

0.00

Interest Coverage ?

3.9

Current Ratio ?

N/A

Ownership

Promoter holding ?

61.71%

Change in promoter holding ?

0.33%

Pledged percentage ?

N/A

Market

Return 3 months ?

30.5%

Return 6 months ?

-0.8%

🗓️ Quarterly results (4 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Jun 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	17	23	27	29	+68.4%	+8.2%
Operating Profit	1	2	2	4	+503.3%	+61.6%
Other Income	0	0	1	0	+340.0%	-63.9%
Interest	0	0	-0	0	-78.6%	+400.0%
Depreciation	1	1	2	1	+2.6%	-23.7%
Profit Before Tax	-1	1	1	3	+503.1%	+101.5%
Net Profit	-1	0	1	2	+347.7%	+61.0%
EPS	-0.39	0.26	0.61	0.98	+351.3%	+60.7%
OPM %	3.5%	8.5%	8.3%	12.4%	+254.3%	+49.4%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	Prev FY	FY26	TTM	YoY %
Sales	—	₹67 Cr	—	—
Operating Profit	—	₹5 Cr	—	—
OPM %	—	7.10%	—	—
NPM %	—	1.15%	—	—
Other Income	—	₹1 Cr	—	—
Depreciation	—	₹4 Cr	—	—
Interest	—	₹0 Cr	—	—
EBIT	—	₹1 Cr	—	—
PBT	—	₹1 Cr	—	—
Tax	—	₹0 Cr	—	—
Net Profit	—	₹1 Cr	—	—
EPS	—	₹0.48	—	—
Material Cost	—	₹8 Cr	—	—
Employee Cost	—	₹4 Cr	—	—
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 1 periods)

Metric	Mar 2026	% Chg
Equity Capital	16.49	—
Reserves	40.37	—
Borrowings	0.00	—
Other Liabilities	15.86	—
Total Liabilities	72.72	—
Fixed Assets	34.12	—
CWIP	0.43	—
Investments	11.77	—
Other Assets	26.40	—
Total Assets	72.72	—

💧 Cash Flow (latest 1 periods)

Metric	Mar 2026	% Chg
Cash from Operating Activity	2.21	—
Cash from Investing Activity	-0.43	—
Cash from Financing Activity	0.05	—
Net Cash Flow	1.83	—
Free Cash Flow	-5.59	—
CFO/OP	48%	—

➗ Ratios (latest 1 periods)

Metric	Mar 2026	% Chg
Debtor Days	24.85	—
Inventory Days	31.71	—
Days Payable	92.91	—
Cash Conversion Cycle	-36.35	—
Working Capital Days	37.11	—

👥 Shareholding (latest 4 periods)

Metric	Dec 2024	Mar 2025	Sep 2025	Mar 2026	% Chg
Promoters	61.38%	61.44%	61.47%	61.71%	+0.4%
FIIs	4.06%	3.50%	3.47%	0.73%	-79.0%
DIIs	3.41%	2.24%	1.04%	1.30%	+25.0%
Public	31.14%	32.82%	34.02%	36.27%	+6.6%
No. of Shareholders	1,077	1,391	1,644	1,845	+12.2%

⚖️ Peer comparison

Industry: Healthcare · 22 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	VIJAYA Vijaya Diagnostic	₹1,507.80	15,530	82.7	857	187	42.3%	21.8%	19.5%	20.2%	22.8%	37.3%
2	METROPOLIS Metropolis Healthcare	₹596.30	12,370	61.1	1,710	203	24.7%	11.9%	23.6%	31.4%	16.6%	25.7%
3	HCG Healthcare Global	₹704.05	10,512	390.9	2,626	33	18.2%	1.3%	14.6%	-53.3%	13.1%	175.3%
4	YATHARTH Yatharth Hospital	₹988.90	9,528	54.1	1,200	171	23.6%	14.3%	36.2%	31.6%	47.6%	16.2%
5	JLHL Jupiter Life	₹277.85	9,109	9.7	1,557	187	22.1%	12.0%	20.9%	-6.7%	18.2%	-14.5%
6	THYROCARE Thyrocare Technologies	₹555.45	8,841	50.0	876	176	32.1%	20.1%	20.8%	79.4%	24.3%	33.2%
7	KOVAI Kovai Medical	₹6,260.50	6,850	26.7	1,644	256	27.9%	15.6%	15.7%	16.7%	15.3%	20.6%
8	INDRAMEDCO Indraprastha Medical	₹363.20	3,330	17.7	1,524	188	18.0%	12.4%	9.3%	13.7%	11.3%	9.5%
9	KRSNAA Krsnaa Diagnostics	₹543.40	1,763	18.1	816	98	26.8%	12.0%	7.8%	31.0%	22.1%	-19.3%
10	SURAKSHA Suraksha Diagnostic	₹311.85	1,624	45.3	325	35	31.4%	10.8%	23.1%	1.4%	20.7%	40.0%
11	SHALBY Shalby	₹132.15	1,418	38.0	1,176	37	12.1%	3.2%	5.0%	1683.0%	11.7%	36.7%
12	GPTHEALTH GPT Healthcare	₹157.90	1,296	27.4	491	48	18.5%	9.8%	15.1%	-21.9%	17.8%	62.5%
13	LAXMIDENTL Laxmi Dental	₹196.21	1,080	35.0	287	31	16.2%	10.9%	16.0%	-10.1%	13.2%	28.9%
14	NEPHROCARE Nephro Care	₹234.80	387	—	—	—	—	—	—	—	68.4%	347.7%
15	LOTUSEYE Lotus Eye	₹114.50	243	n/m	57	0	8.5%	0.3%	8.4%	-89.1%	26.2%	13.0%
16	UNIHEALTH Unihealth Hospitals	₹121.00	190	6.5	132	46	40.9%	34.8%	—	—	104.6%	71.5%
17	MADHAVBAUG Vaidya Sane	₹148.00	156	19.1	147	8	11.4%	5.6%	—	—	116.1%	94.3%
18	MHHL Mohini Health	₹57.05	104	—	145	-17	-1.4%	-11.7%	—	—	-6.6%	-1400.0%
19	MAITREYA Maitreya Medicare	₹120.65	82	—	45	-2	-1.0%	-5.5%	—	—	-5.2%	-1720.0%
20	AATMAJ Aatmaj Healthcare	₹26.75	60	83.6	24	1	9.7%	2.9%	—	—	22.5%	-39.4%
21	NIDAN Nidan Laborator.	₹33.00	46	30.6	26	2	19.0%	5.9%	—	—	-11.2%	-92.0%
22	ARTEMISMED Artemis Medicare	₹315.00	—	48.0	1,081	103	17.4%	9.6%	15.4%	25.9%	16.3%	30.9%

❓ Frequently asked questions

What was Nephro Care India Limited's revenue in Q1 FY27?

What was Nephro Care India Limited's net profit in Q1 FY27?